RedHill Biopharma (RDHL) Change in Inventory (2017 - 2022)

RedHill Biopharma (RDHL) has 6 years of Change in Inventory data on file, last reported at $1.6 million in Q4 2022.

• On a quarterly basis, Change in Inventory rose 192.87% year-over-year to $1.6 million in Q4 2022; TTM through Dec 2022 was $3.8 million, a 145.88% increase from a year earlier, with the FY2025 full-year figure at -$375000.0, down 150.81% from the prior year.
• Change in Inventory for Q4 2022 stood at $1.6 million, up from -$865000.0 in the prior quarter.
• Over the last five years, Change in Inventory for RDHL reached as high as $2.6 million in Q2 2022 and fell as low as -$4.4 million in Q3 2021.
• Historically, Change in Inventory has averaged -$517850.0 across 5 years, with a median of -$325000.0 in 2018.
• Across the five-year window, Change in Inventory sank 1905.06% in 2020 and soared 403.55% in 2022, its largest moves.
• Year by year, Change in Inventory stood at -$300000.0 in 2018, then surged by 126.33% to $79000.0 in 2019, then sank by 1905.06% to -$1.4 million in 2020, then slipped by 18.93% to -$1.7 million in 2021, then soared by 192.87% to $1.6 million in 2022.
• Per Business Quant data, the three most recent Change in Inventory figures were $1.6 million in Q4 2022, -$865000.0 in Q3 2022, and $2.6 million in Q2 2022.